Ameriprise Financial Inc Xeris Biopharma Holdings, Inc. Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 209,923 shares of XERS stock, worth $957,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209,923
Previous 217,089
3.3%
Holding current value
$957,248
Previous $618,000
15.05%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$47.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$15.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$15.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$13.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $620M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...